Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The Food and Drug Administration (FDA ... IHC 1+ or IHC 2+/in situ hybridization [ISH]-) breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...